Additionally, HO-1 and NRF2 levels were significantly altered following ATO treatment, and since both proteins exhibit dual roles in cancer progression, it is crucial to thoroughly investigate their context-dependent functions in HCC treatment. This evidence concerns the gene HMOX1 and cancer.